Viveve Medical, Inc.

Viveve Medical, Inc.

VIVE
Viveve Medical, Inc.US flagNASDAQ Capital Market
-0.66EPS
-NaNMarket Cap
Oct 03Next Earn
Viveve Medical, Inc.
VIVE
(NASDAQ Capital Market)

Recent

price

0.00

P/E

ratio

0

div

yld

- -

ROIC.AI

Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Business
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Company News

  • Why Is Viveve Medical (VIVE) Stock Down 69% Today?

  • Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript

  • Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

  • Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript

  • Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022

  • Viveve to Participate in H.C. Wainwright Global Investment Conference

  • Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript

  • Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022

  • Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript

  • Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript

  • Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update

  • Are Biotech Penny Stocks Worth Buying? Check These 3 Out

  • Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

  • Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript

  • Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update

  • VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened

  • Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent

  • Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference

  • Viveve Announces Issuance of New Device and Methods Patent in U.S.

  • Viveve Announces Adjournment of Annual Meeting